|
Wed, 01/18/2023 - 02:10 |
Liquid Biopsy Market in US to Experience 6-8 percent Growth by 2028: Makreo Research and Consulting Report |
Makreo Research |
|
Wed, 01/04/2023 - 05:06 |
United States Liquid Biopsy Market Expected to Grow at Double-Digit CAGR, According to Makreo Research |
Makreoresearch |
|
Tue, 01/03/2023 - 10:39 |
Get to live the way you choose with Global Soul Healing |
GLOBAL SOUL HEALING |
|
Mon, 12/26/2022 - 23:02 |
New technique improves high-intensity focused ultrasound treatment for brain disorders |
UTSouthwestern |
|
Wed, 12/21/2022 - 18:39 |
MSF trial finds better treatment for people with TB |
Doctors Without... |
|
Tue, 12/20/2022 - 19:02 |
Foundation Medicine Receives FDA Approval for FoundationOneLiquid CDx as a Companion Diagnostic for a Certain Group of Tyrosine Kinase Inhibitors for Treatment of Non-Small Cell Lung Cancer Patients |
Foundation Medicine |
|
Tue, 12/20/2022 - 18:45 |
Chickasha Animal Rescue Transportation Association Receives $5,000 Grant From Arvest Foundation |
Arvest |
|
Tue, 12/20/2022 - 10:34 |
Robotic bronchoscopy may offer solution to lung biopsy risks |
UTSouthwestern |
|
Tue, 12/20/2022 - 08:55 |
MediGO is Latest Recipient of National Kidney Foundation Innovation Fund Investment |
National Kidney... |
|
Fri, 12/16/2022 - 19:15 |
FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer |
FDA |
|
Thu, 12/15/2022 - 21:24 |
Ferring Receives Approval from U.S. FDA for Adstiladrin for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer |
Ferring Pharmac... |
|
Thu, 12/15/2022 - 15:49 |
Take Lifesaving Steps to End Lung Cancer at San Diego LUNG FORCE Walk, Sunday |
American Lung A... |
|
Thu, 12/15/2022 - 13:36 |
WHO recommends TB regimen found effective by MSF clinical trial |
Doctors Without... |
|
Thu, 12/15/2022 - 03:41 |
Kintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma (DIPG) |
DelMar Pharmace... |
|
Tue, 12/13/2022 - 18:18 |
Al B. Sure! Gives First Interview After Waking from Two-Month Long Coma |
TV One |
|
Mon, 12/12/2022 - 12:59 |
Inhibikase Therapeutics Announces Dosing of First Subjects in its '501' Bioequivalence Study of IkT-001Pro |
Inhibikase Ther... |
|
Mon, 12/12/2022 - 06:49 |
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine |
Biodesix |
|
Sun, 12/11/2022 - 10:16 |
CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial |
Dana Farber |
|
Sat, 12/10/2022 - 20:40 |
Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome |
Dana Farber |
|
Sat, 12/10/2022 - 10:18 |
Janssen Presents New Data for Talquetamab, a First-in-Class GPRC5DxCD3 Bispecific Antibody, Suggesting Durable Responses in Patients with Heavily Pretreated Multiple Myeloma |
Johnson and Johnson |
|
Fri, 12/09/2022 - 14:56 |
Galderma, the pure-play dermatology category leader and maker of Cetaphil, celebrates grand opening of U.S. headquarters in Dallas |
Galderma |
|
Wed, 12/07/2022 - 15:05 |
UTSW researchers discover rare premature-aging syndrome |
UTSouthwestern |
|
Tue, 12/06/2022 - 16:03 |
Overlake Medical Center Again Named a Best Hospital for Maternity by U.S. News & World Report |
Overlake Hospital |
|
Mon, 12/05/2022 - 10:42 |
EndoGastric Solutions, Inc. Announces CEO Transition and $18M Financing to Expand Commercialization |
EndoGastric Sol... |
|
Wed, 11/30/2022 - 18:43 |
New Treatment Strategy Could Boost Efficacy of Immunotherapy in Patients With Solid Tumors |
Roswell Park Ca... |
